CFO
WVE icon

CVA Family Office’s Wave Life Sciences WVE Stock Holding History

CVA Family Office’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831 Buy
+143
New +$948 ﹤0.01% 1667
2026
Q1 		– Sell
-128
Closed -$2.18K – 1876
2025
Q4 		$2.18K Buy
+128
New +$1.3K ﹤0.01% 979

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

CVA Family Office's WVE Position: Q2 2026 in Review

CVA Family Office opened a new position in Wave Life Sciences (WVE) in Q2 2026: 143 shares worth $831. The stake represents ﹤0.01% of the portfolio and ranks #1667 among its holdings. This is a return to the name: CVA Family Office previously reported a position in WVE as recently as Q4 2025.

CVA Family Office first reported a position in WVE in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.18K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • CVA Family Office held 143 shares of Wave Life Sciences worth $831 as of Q2 2026.
  • Wave Life Sciences was a new CVA Family Office position in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1667 holding.
  • CVA Family Office first reported a position in Wave Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • CVA Family Office's Wave Life Sciences position peaked at $2.18K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.